[ad_1]
According to “Reuters”, the Russian direct investment fund said the drug showed promising results in the first clinical trials in Russia.
He added that the investment fund provided 150 million rubles, equivalent to about two million dollars to finance the project.
The agency quoted the CEO of the Russian Direct Investment Fund, Kirill Dimitriev, as saying that the test results of 60% of the 40 patients with the Corona virus who took the drug faviravir, which was first developed in Japan under the Avigan name, negative in 5 days.
Dmitriyev explained that the drug can cut in half the time it takes to recover from the Corona virus.
Reuters indicated that the Avicane drug known as faviravir was developed in the late 1990s by a company bought by Fujifilm when the latter began to change its business and switched to medical care.
The Indian company, Glenmark Pharmaceuticals, is also investigating favapiravir.
It is noteworthy that Egypt was the first country in which Japan participated in the use of the drug “Avigan” in clinical trials to treat people infected with Coronavirus.
[ad_2]
